Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

類似資料

• Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical onchocerca volvulus infection
  著者:: Soboslay, P. T., 等
  出版事項: (1994)
• Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy
  著者:: Mai, C S, 等
  出版事項: (2007)
• Chemokines in onchocerciasis patients after a single dose of ivermectin
  著者:: Fendt, J, 等
  出版事項: (2005)
• Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
  著者:: Banla, Méba, 等
  出版事項: (2014)
• Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease
  著者:: LÜDER, C G K, 等
  出版事項: (1996)